Image Sourced Mach7 Technologies Limited
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Mach7 Technologies (M7T) signs a contract renewal with Cabell Huntington Hospital in Huntington, West Virginia for a total value of $2.8 million
  • The agreement is for a five-year renewal of Cabell’s Enterprise Imaging Platform along with a five-year renewal on support for the eUnity Diagnostic Enterprise Viewer
  • This renewal converts the existing capital term licence agreement with Cabell to a five-year subscription-based agreement based on image volume
  • According to Mach7, subscription renewals on average have 20 per cent greater overall value than capital licence over the full term
  • Shares in Mach7 are up 3.09 per cent, trading at 50 cents at market close

Mach7 Technologies (M7T) has signed a contract renewal with Cabell Huntington Hospital in Huntington, West Virginia for a total value of $2.8 million.

The agreement is for a five-year renewal of Cabell’s Enterprise Imaging Platform along with a five-year renewal on support for the eUnity Diagnostic Enterprise Viewer.

This renewal converts the existing capital term licence agreement with Cabell to a five-year subscription-based agreement based on image volume.

Mach7 CEO Mike Lampron said the continued support from the company’s existing clients is pleasing.

“This long-term commitment shows the value that Mach7 brings to our clients across the
enterprise,” he said.

“The conversion from a capital model to a subscription model further shows a developing
trend that we are seeing in our business model.

“While this has an impact on the current reporting period, the revenue is contracted and will be recognised annually; overtime, showing greater value and revenue consistency on an annual basis.”

The company said the annual recurring revenue value will begin to recognised on a quarterly basis in the first quarter of the next fiscal year.

According to Mach7, subscription renewals on average have 20 per cent greater overall value than capital licence over the full term.

Shares in Mach7 were up 3.09 per cent, trading at 50 cents at market close.

M7T by the numbers
More From The Market Herald

" Chalice Mining (ASX:CHN) intersects new zone at Dampier, Julimar

Chalice Mining (ASX:CHN) intersects a new nickel-copper-platinum group elements (PGE) sulphide zone in initial drilling at…
The Market Herald Video

" Genmin (ASX:GEN) strikes royalty deal with Anglo American over Baniaka project, Gabon

Genmin (ASX:GEN) has struck a royalty agreement with Anglo American's subsidiary, Anglo American Marketing, over the…
The Market Herald Video

" Great Boulder Resources (ASX:GBR) hits “spectacular” intercept at Mulga Bill

Great Boulder Resources (ASX:GBR) has received assays from the final two diamond holes drilled at the…
The Market Herald Video

" ResApp (ASX:RAP) extends Medgate licence agreement in line with expansion plans

ResApp Health (ASX:RAP) has agreed to a 12 month extension to its commercial licence agreement with…